Skip to main content
. Author manuscript; available in PMC: 2013 Jul 15.
Published in final edited form as: Bioorg Med Chem Lett. 2012 Jun 6;22(14):4585–4592. doi: 10.1016/j.bmcl.2012.05.101

Table 1.

Assays of the inhibition of hDAGLα (radio-TLC assay with [14C]SAG substrate),37 rFAAH,57 and hMAGL63 enzyme activities

Compound Number Detail of N-formyl- α-amino ester hDAGLα inhibition at 10 μM detergent free or (with Triton X-100) (%) rFAAH inhibition at 10 μM (%) hMAGL inhibition at 10 μM (%)
3 (THL) L-leucyl 100, (100A) 6 47
4 (OMDM-188) L-isoleucyl (98A) 7 16
5 L-allo-isoleucyl (95A) 3 1
6 D-isoleucylC (78A) 28 39
7 D-allo-isoleucyl (86A) 0 42
8 (S)-α-aminobutyryl (99A) 12 45
9 none (25A, 45B) 10 4
trans-10 none (37B) 79 55
cis-11 none (25B) 94D 100D
JZL184 NA (37B) 97E 100F
URB597 NA ND 100E 18
n-C16H33SO2F NA ND 100E 82
PMSF NA 19 100E 5
RHC80267 (1) NA 30 95E 22
SD41 NA <0* 10 13

NA, not applicable; ND, not done

A

0.05% Triton X-100 present

B

0.015% Triton X-100 present

C

5% impurity in D-isoleucyl analog due to D-allo-isoleucyl analog

D

cis-11 inhibits rFAAH only 13% at 1 μM, but inhibits hMAGL 66% at 100 nM

E
8 pt rFAAH IC50 (95% confidence)
JZL184 974 nM (784–1210)
URB597 4.9 nM (4.1–6.0)
n-C16H33SO2F 6.3 nM (4.5–8.7)
PMSF 833 nM (746–931)
RHC80267 (1) 2,240 nM (2010–2500)
F

8 pt hMAGL IC50 (95% confidence)

JZL184 57 nM (53–62)
*

protein was pretreated with JZL184 to completely inhibit MAGL activity